Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
Quick Facts
What This Study Found
Bremelanotide improved sexual desire and reduced distress in 1202 patients across most subgroups.
Key Numbers
How They Did This
The study involved 1202 patients who self-administered bremelanotide 1.75 mg or a placebo for 24 weeks, with efficacy measured using specific sexual function scales.
Why This Research Matters
This research provides evidence that bremelanotide can effectively treat HSDD in various demographics, potentially improving quality of life for many women.
What This Study Doesn't Tell Us
The study may not fully represent all women with HSDD, and results from clinical trials may not always translate to real-world settings.
Trust & Context
- Original Title:
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
- Published In:
- Journal of women's health (2002), 31(3), 391-400 (2022)
- Authors:
- Simon, James A, Kingsberg, Sheryl A, Portman, David, Jordan, Robert, Lucas, Johna, Sadiq, Amama, Krop, Julie, Clayton, Anita H
- Database ID:
- RPEP-06503
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06503APA
Simon, James A; Kingsberg, Sheryl A; Portman, David; Jordan, Robert; Lucas, Johna; Sadiq, Amama; Krop, Julie; Clayton, Anita H. (2022). Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.. Journal of women's health (2002), 31(3), 391-400. https://doi.org/10.1089/jwh.2021.0225
MLA
Simon, James A, et al. "Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.." Journal of women's health (2002), 2022. https://doi.org/10.1089/jwh.2021.0225
RethinkPeptides
RethinkPeptides Research Database. "Prespecified and Integrated Subgroup Analyses from the RECON..." RPEP-06503. Retrieved from https://rethinkpeptides.com/research/simon-2022-prespecified-and-integrated-subgroup
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.